Fractional ablative laser Examples of laser types: CO₂ and Er:YAG | Resurfacing and treatment of selected textural concerns, with downtime that varies by settings, treatment area, and patient. | Clinics with appropriately trained practitioners, suitable patient pathways, and capacity to manage post-treatment care. | Confirm the intended indications, selectable treatment parameters, consumables, maintenance schedule, and availability of clinical documentation for the exact model. | Can cause burns, pigment changes, infection, scarring, or eye injury. Requires appropriate eye protection, infection-control procedures, and careful patient selection. | Check market-specific authorization and the device’s stated indications. Verify applicable laser-safety requirements and electrical safety documentation; a certificate alone does not establish clinical suitability. | Ask about operator training, service response times, spare parts, preventive maintenance, and escalation procedures for adverse events. |
| Non-ablative fractional laser | Fractional dermal heating for selected skin texture and appearance concerns, generally without ablating the full treated surface. | Buyers seeking a fractional laser option with a different downtime and treatment profile from ablative resurfacing. | Compare wavelength, energy and density controls, treatment indications, published evidence, and the expected number and spacing of sessions. | Redness, swelling, pigment alteration, burns, and eye injury are possible. Risk varies by device, settings, skin characteristics, and operator technique. | Confirm the exact device and indication are authorized in the destination market. Review applicable laser and medical electrical equipment documentation. | Confirm training materials, local-language instructions where required, calibration and repair arrangements, and access to technical support. |
| Radiofrequency microneedling | Combines needle-based skin penetration with radiofrequency energy for selected textural and remodeling applications. | Clinics able to manage an invasive procedure, single-use or reprocessing requirements, and follow-up care. | Check needle depth and energy controls, approved indications, handpiece design, cartridge compatibility, consumable costs, and evidence for the specific model. | May cause pain, bleeding, infection, burns, scarring, or pigment changes. Use only as directed, with appropriate aseptic technique and patient screening. | Verify regulatory status for the complete system and its accessories in each sales market. Confirm whether cartridges are single-use and how that requirement is documented. | Confirm reliable consumable supply, staff competency training, traceability of cartridges, complaint handling, and service access. |
| Intense pulsed light (IPL) | Broad-spectrum light treatment for selected pigment, vascular, or photo-rejuvenation indications, depending on the device and authorization. | Buyers seeking a light-based platform whose filters and indications match their intended patient population and local rules. | Review wavelength or filter options, pulse controls, cooling method, treatment indications, and evidence for each intended use. | Possible risks include burns, blistering, eye injury, and pigment changes. Treatment suitability depends on the device instructions, skin characteristics, and operator assessment. | Check whether the device is legally marketed for each intended use in the destination country. Do not assume one market’s authorization applies elsewhere. | Ask about filter and handpiece availability, maintenance, operator training, service turnaround, and replacement-part costs. |
| Microfocused ultrasound | Focused ultrasound energy for selected tissue-targeting and skin-tightening indications, subject to device labeling and local authorization. | Clinics with trained operators and a clear process for selecting suitable treatment areas and patients. | Check transducer options, treatment-depth claims, energy settings, imaging or guidance features if present, and evidence tied to the exact model. | Discomfort, swelling, bruising, burns, or nerve-related injury may occur. Safe use depends on correct anatomy, settings, and operator training. | Verify the authorized indications, transducers, and treatment areas in the target market; review the device’s labeling and applicable medical-device documentation. | Confirm transducer availability and traceability, training, maintenance, and the process for reporting and investigating adverse events. |
| General-purpose buying checks | Applies to all categories and should be completed before purchase, import, installation, or clinical use. | All distributors, clinics, hospitals, and other professional buyers operating across borders. | Request the exact model and configuration, intended-use statement, instructions for use, clinical evidence, warranty terms, and a full cost-of-ownership estimate. | Assess operator qualifications, patient screening, contraindications, protective equipment, cleaning or reprocessing instructions, and emergency procedures. | Verify device-specific authorization with the relevant national regulator. FDA clearance or authorization is specific to the device and indication; establishment registration or listing alone is not FDA approval. For Europe, verify applicable CE marking and conformity-assessment documentation under the relevant rules. Check local import and licensing requirements. | Agree on installation, training, local-language documentation where required, warranty coverage, service levels, spare parts, software updates, and complaint and recall procedures. |